PTC-124

Hazard statements (CLP)

H336, H373

Code

Statements

H336

May cause drowsiness or dizziness

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Specific target organ toxicity - H336 May cause drowsiness or dizziness single exposure, (Category 3), Central nervous system Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure. Kidney

2.2 Label elements

Labelling

Signal word

Warning Warning

Hazard statements

H336 May cause drowsiness or dizziness. H373 May cause damage to organs (Kidney) through prolonged or repeated exposure. Reduced Labeling (<= 125 ml) none

Precautionary statements

P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P271 Use only outdoors or in a well-ventilated area. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P314 Get medical advice/ attention if you feel unwell. P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up. none

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.